Remove tag
article thumbnail

The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank

HIT Consultant

Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The growing number of promising but expensive treatments present a challenge – to governments, caregivers, insurance companies, and ordinary citizens. And for decades, no definitive answer or policy has been found.

article thumbnail

Day 4 Notes from the 41st Annual J.P. Morgan Healthcare Conference

Healthcare Law Blog

A lot of the week was spent with health plans and Medicare Advantage or Medicaid focused providers or management companies extolling the virtues of “whole person health,” “coordinated care” and other similar approaches. There are a lot of “blockbuster” drugs coming to market today and in the near future with eye-watering price tags.